Evidence map›Paper›PMID 30377904›Full record

ArticleJournal of natural medicines2019

Betulinic acid attenuates liver fibrosis by inducing autophagy via the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway.

Yuan Liu, Yanmeng Bi, Chan Mo, Ting Zeng, Sha Huang, Lei Gao, Xuegang Sun, Zhiping Lv

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of natural medicines, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yuan LiuSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, China.
Yanmeng BiSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, China.
Chan MoSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, China.
Ting ZengSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, China.
Sha HuangSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, China.
Lei GaoSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, China.
Xuegang SunSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, China. sxg_smu@126.com.
Zhiping LvSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, China. lzp48241@126.com.ORCID http://orcid.org/0000-0003-2796-526X
Southern Medical University · CNState Administration of Traditional Chinese Medicine of the People's Republic of China · CNTCM-Intigrated Cancer Center of Southern Medical University · CN

Funding

Administration of Traditional Chinese Medicine of Guangdong Province 20162087Guangdong Science and Technology Department (CN) 2014A020221097National Natural Science Foundation of China (CN) 81603501National Natural Science Foundation of China (CN) 81774170Science and Technology Planning Project of Guangzhou City 201508020014Science and Technology Planning Project of Guangzhou City 201707010080the Natural Science Foundation of Guangdong Province 2018B030306012the Scientific Research Initiative Program of Southern Medical University CX2017N001the Scientific Research Initiative Program of Southern Medical University LX2015N003
6 · The paper itself

Abstract

The present study was designed to investigate the effects of betulinic acid on human hepatic stellate cells in vitro and C57BL/6 mice in vivo, as well as the signaling pathways involved. In this study, we explored the effects of betulinic acid on expression of alpha smooth muscle actin and autophagy-related proteins. Betulinic acid reduced pathological damage associated with liver fibrosis, as well as serum platelet-derived growth factor and serum hydroxyproline levels. Furthermore, betulinic acid downregulated the expression of alpha smooth muscle actin and type I collagen in mouse liver and upregulated the expression of microtubule-associated protein light chain 3B and autophagy-related gene 7 at the gene and protein levels. LC3II expression was increased and alpha smooth muscle actin expression was decreased in betulinic acid-treated hepatic stellate cells. Interventions with bafilomycin A1 and mCherry-GFP-LC3 adenoviruses promoted the formation of autophagosomes in hepatic stellate cells and the development of autophagic flow. Our study found that mitogen-activated protein kinase/extracellular signal-regulated kinase may be involved in the effects of betulinic acid on liver fibrosis. The present study suggests that betulinic acid has anti-hepatic fibrosis activity by inducing autophagy and could serve as a promising new agent for treating hepatic fibrosis.

Indexed as

AnimalsAutophagyBetulinic AcidExtracellular Signal-Regulated MAP KinasesHumansLiver CirrhosisMice, Inbred C57BLPentacyclic TriterpenesTriterpenesBetulinic AcidExtracellular Signal-Regulated MAP KinasesPentacyclic TriterpenesTriterpenesAutophagyBafilomycin A1Betulinic acidLiver fibrosisMAPK/ERK

Identifiers

PMID30377904
OpenAlexW2899266362

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.